financetom
Business
financetom
/
Business
/
Lowe's Looks to Possible Offering of Stock, Debt
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lowe's Looks to Possible Offering of Stock, Debt
Jul 19, 2024 8:06 AM

10:41 AM EDT, 07/19/2024 (MT Newswires) -- Lowe's (LOW) on Friday disclosed plans in a regulatory filing for a potential offering of common stock, preferred stock or debt securities.

The retailer did not indicate how much it might seek to raise but said net proceeds would be used for for general corporate purposes, including stock buybacks, paying down debt, capital projects, future acquisitions or strategic investments.

Price: 239.60, Change: +0.23, Percent Change: +0.10

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Venezuela's PDVSA to cut office hours as power crisis worsens
Venezuela's PDVSA to cut office hours as power crisis worsens
Mar 28, 2025
(Reuters) - Venezuelan state-run oil firm PDVSA will cut office hours for its administrative workers, an internal document seen by Reuters showed, following an energy-saving order by the government amid a worsening power crisis. The administration of President Nicolas Maduro announced on Sunday that government offices would cut their hours to half as reduced generation of hydro electricity and a...
US FDA approves Sanofi's bleeding disorder therapy
US FDA approves Sanofi's bleeding disorder therapy
Mar 28, 2025
March 28 (Reuters) - The U.S. Food and Drug Administration approved French drugmaker Sanofi's therapy, paving the way for a new type of treatment for patients 12 years of age and older with a rare disorder that prevents blood from clotting properly, the regulator said on Friday. ...
US FDA approves Sanofi's bleeding disorder therapy
US FDA approves Sanofi's bleeding disorder therapy
Mar 28, 2025
(Reuters) -The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, paving the way for a new type of treatment for patients with the rare blood clotting disorder, the regulator said on Friday. Sanofi's subcutaneous, or under-the-skin, therapy helps prevent bleeding and lowers antithrombin, a protein that delays blood clotting, for hemophilia patients aged 12 years and older....
Column-Kroger and Albertsons play blame game after failed merger in billion-dollar battle
Column-Kroger and Albertsons play blame game after failed merger in billion-dollar battle
Mar 28, 2025
(No changes to text.) By Jenna Greene March 28 (Reuters) - Breakups are rarely easy, but the acrimony over a busted blockbuster deal can rival finger-pointing by the bitterest of star-crossed lovers. Consider the blame game unfolding now between Kroger ( KR ) and Albertsons ( ACI ) in Delaware Chancery Court, where each grocery chain is attempting to fault...
Copyright 2023-2026 - www.financetom.com All Rights Reserved